Escitalopram for agitation in Alzheimer’s dementia: a randomized controlled phase 3 trial
Tarek K. Rajji, Sheriza Baksh, David Shade, Zahinoor Ismail, Amer M. Burhan, Hamid Okhravi, Prasad R. Padala, Paul B. Rosenberg, Lon S. Schneider, Anton P. Porsteinsson, Constantine G. Lyketsos
Topics & Concepts
EscitalopramRandomized controlled trialDementiaMedicineAlzheimer's diseasePsychiatryPsychologyInternal medicineDiseaseAnxietyAntidepressantDementia and Cognitive Impairment ResearchSchizophrenia research and treatmentPsychosomatic Disorders and Their Treatments